Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance

Telik Announces Presentation and Webcast at 12th Annual Bio CEO & Investor Conference

Telik Announces INITIATION of Phase 1 clinical Study of Ezatiostat Hydrochloride (TELINTRA®, TLK199) TABLETS in Combination with lenalidomide (Revlimid®) in patients with MyeLodysplastic Syndrome (MDS)